Immobazyme
PrivateLast Round
VC Round
Dec 1, 2025
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Immobazyme operates in Healthcare & Life Sciences and is based in Cape Town. Its latest recorded funding round was a VC Round in December 2025.
Immobazyme is a biotechnology company that develops and manufactures high-value biological products, including recombinant growth factors, enzymes, and peptides, using a proprietary precision fermentation and enzyme immobilization platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immobazyme Comparables
Compare Immobazyme with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sticta Biologicals | 85% | |
| Cascade Bio | 74% | |
| EnginZyme | 71% |
For institutional investors. Book with your work email.
Immobazyme Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 1, 2025 | ||||
| VC Round | Jun 18, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Immobazyme Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fireball Capital | VC Round |
| Innovus | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 243% MoM, reaching 885.
- Feb 23, 2026
Grew 31% QoQ, from 13 to 17 employees.
For institutional investors. Book with your work email.
Immobazyme Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Immobazyme's valuation, stock price, and market status.
Is Immobazyme a public or private company?
Immobazyme is a private company.
What is the current stock price of Immobazyme?
Immobazyme is a private company, so its shares have no public market price. Caplight tracks Immobazyme's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Immobazyme worth (valuation)?
Valuation information for Immobazyme is not publicly available.
Can I buy Immobazyme stock?
Immobazyme shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Immobazyme's last funding round?
Immobazyme's most recent funding round was VC Round on December 1, 2025.
Who are the main investors in Immobazyme?
Key investors in Immobazyme include Innovus.
Will Immobazyme IPO soon?
No public IPO plans have been announced for Immobazyme.
How can I track Immobazyme secondary market activity?
Caplight tracks bids, offers, and trades in Immobazyme's shares on secondary markets.